Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Peter Hotez

Monkeypox vaccine: What you should know about possible side effects and ‘the lump’

If you have any fears of potential side effects, don’t hesitate to discuss them with medical personnel at your vaccination site or your own health care provider.

Chicago Sun-Times

Monkeypox risk in schools: Here's what parents need to know

A 2005 study found that children under the age of eight are most likely to have severe outcomes from monkeypox, though experts say that’s far from definitive.

Inverse

Back-to-school, back to outbreaks

As students around the country start a new school year, providers say childhood immunization rates are too low, in some places, to prevent outbreaks of diseases like measles.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Fighting monkeypox, sexual health clinics are underfunded, ill-equipped

Sexual health clinics have been stretched so thin that many lack the staff to perform such basic duties as contacting and treating the partners of infected patients.

Chicago Sun-Times

Fighting monkeypox, sexual health clinics are underfunded and ill-equipped

Clinics that treat sexually transmitted diseases — already struggling to contain an explosive increase in infections such as syphilis and gonorrhea — now find themselves on the front lines in the nation’s fight to control the rapidly growing monkeypox outbreak.

Tribune News Service

BA.5 Covid-19 infections: What it means for the pandemic and booster shots

The new subvariant is responsible for a massive wave of new infections.

Inverse

For now, wary US treads water with transformed COVID-19

The fast-changing coronavirus has kicked off summer in the U.S. with lots of infections but relatively few deaths compared to its prior incarnations

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Novavax missed its global moonshot but is angling to win over mRNA defectors

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its COVID-19 vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

Tribune News Service

Alex Jones promotes false conspiracy that monkeypox outbreak is due to Covid-19 vaccines

The monkeypox outbreak theory is just the latest unproven claim to be promoted by the anti-vaxer

The Independent UK

Alex Jones promotes false conspiracy that monkeypox outbreak is due to Covid-19 vaccines

The monkeypox outbreak theory is just the latest unproven claim to be promoted by the anti-vaxer

The Independent UK

The high-stakes push to get COVID vaccines to young children

The Omicron variant and and anti-vaccine backlash are complicating the effort.

Axios

As Connecticut’s COVID-19 numbers improve, what’s next? Experts are optimistic — with some important caveats

HARTFORD, Conn. — For at least the third time in the past two years, Connecticut finds itself moving past a devastating COVID-19 surge and hoping its coronavirus nightmare may finally be reaching an end.

Tribune News Service

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Serum Institute of India

23 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.